In line with the native C3 protein data, qPCR analysis showed a significant>2-fold decreased C3 mRNA expression in subjects with NASH compared to control subjects (1.00±0.23 vs. 0.46±0.09; p<0.05; figure 2E). This evidence concerns the gene C3 and metabolic dysfunction-associated steatohepatitis.